Renalytix PLC (RENX)

Industry Health Information Services

This stock can be held in an Investment ISA, SIPP and Investment Account

Sell

6.00p

Buy

6.50p

arrow-up0.00p (+0.00%)

Prices updated at 12 Dec 2025, 16:18 GMT

Prices minimum 15 mins delay

Prices in GBX

FTSE All-Share

-0.48%

LSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Health Information Services

Chairman

Mr. Julian Huw Baines MBE

CEO

Mr. James Renwick McCullough

Most recent earnings

30 Jun 2025

Fiscal year end

30 Jun 2025

Employees

47

Head office

2 Leman Street

London

United Kingdom

E1W 9US

+44 2031392910

-

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Mr. Christopher Harwood Bernard Mills Non-Executive Director	-
Dr. Erik Lium Non-Executive Director	-
Ms. Catherine Havlik Coste Non-Executive Director	-
Mr. Robert Graham Naylor Non-Executive Director	-
Mr. Fergus Fleming Executive Director, Chief Technical Officer	-
Mr. James Renwick McCullough Executive Director, Chief Executive Officer	-
Mr. Julian Huw Baines MBE Executive Director, Chairman	-

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
Unicorn Asset Management Ltd	25,797,882
Unicorn AIM VCT Series 3 ORD	25,797,882
Abrdn Inc	15,916,835
abrdn World Healthcare Fund	15,916,835
Ruffer LLP	8,500,000

Director dealings

Date chevron-l-regular chevron-r-regular	Action
20 Dec 2024	Purchase

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.